Skip to content

Effect of Foot Reflexology on Physiologic Jaundice in Healthy Infants

Effect of Foot Reflexology on Physiologic Jaundice in Healthy Infants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015100424349N1
Enrollment
60
Registered
2015-10-18
Start date
2015-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Physiologic Jaundice. Neonatal jaundice, unspecified

Interventions

Intervention 1: In the control group no intervention on infants will be made. Intervention 2: The placebo group will be received foot reflexology at the first 12 hours of birth, 4 times, every 3 hours
Treatment - Other
Prevention
In the control group no intervention on infants will be made.
The placebo group will be received foot reflexology at the first 12 hours of birth, 4 times, every 3 hours on the sham point in each feet for 15 minutes and overall 30 minutes
The intervention group will be received foot reflexology at the first 12 hours of birth, 4 times, every 3 hours on the large intestine and colon point in the sole of each feet for 15 minutes and overa

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 1 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria: infants with gestational age 37-42 weeks, birth weight 2500-4000gr, birth total bilirubin level less than 5mg/dl, lack of an obvious jaundice on the 1st day of birth, born with normal delivery without complications, not passing meconium before the intervention, not having contraindication for massage soles of feet, cutting the umblical cord in the first 1-5 minutes of birth, not having blood group incompatibility, obscene of known disease affecting on jaundice in mother and infant and not delaying in breast-feeding. Exclusion criteria: using the antibiotics and drugs that reduce bilirubin level, needs for hospitalization, photo therapy or blood exchange, discontinuation or lack of exclusive breast-feeding, fever, diarrhea and any complications or medical problems that make the intervention impossible.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Level of Transcutaneous Bilirubin. Timepoint: First Study, End Study. Method of measurement: Transcutaneous Bilirubinometer.

Secondary

MeasureTime frame
Clinical Jaundice. Timepoint: First Study, End Study. Method of measurement: Kramer Chart.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEsmaili Mahboobeh

Valiasr Hospital

esmaili.m1368@gmail.com+98 56 3244 3000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026